Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

Abstract
The prognosis of glioblastoma, the most malignant type of glioma, is still poor, with only a minority of patients showing long-term survival of more than three years after diagnosis. To elucidate the molecular aberrations in glioblastomas of long-term survivors, we performed genome- and/or transcriptome-wide molecular profiling of glioblastoma samples from 94 patients, including 28 long-term survivors with >36 months overall survival (OS), 20 short-term survivors with
Study/Project
ID (DOI)
10.1002/ijc.28836
Publication Date
Corresponding Author
Prof. Dr. G. Reifenberger
Corresponding Author Institution

Department of Neuropathology
Heinrich Heine University
Moorenstraße 5
40225 Düsseldorf

Corresponding Author email
reifenberger@med.uni-duesseldorf.de
Disease
Publisher
Int J Cancer.
Grant
German Cancer Aid (Deutsche Krebshilfe); Grant number: 70-3163-Wi 3